Northern Trust Corp Neoleukin Therapeutics, Inc. Transaction History

Northern Trust Corp

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$0.68 - $0.91 $152 - $203	-224 Reduced 0.32%	69,541 $57,000
Q3 2022 Nov 14, 2022	SELL	$0.69 - $1.33 $86 - $166	-125 Reduced 0.18%	69,765 $45,000
Q2 2022 Aug 12, 2022	SELL	$0.92 - $2.25 $219,832 - $537,633	-238,948 Reduced 77.37%	69,890 $72,000
Q1 2022 May 13, 2022	SELL	$1.72 - $5.23 $30,373 - $92,356	-17,659 Reduced 5.41%	308,838 $581,000
Q4 2021 Feb 08, 2022	SELL	$4.65 - $7.75 $115,743 - $192,905	-24,891 Reduced 7.08%	326,497 $1.57 Million
Q3 2021 Nov 15, 2021	SELL	$6.05 - $9.66 $79,279 - $126,584	-13,104 Reduced 3.6%	351,388 $2.54 Million
Q2 2021 Aug 13, 2021	SELL	$9.23 - $13.12 $87,343 - $124,154	-9,463 Reduced 2.53%	364,492 $3.36 Million
Q1 2021 May 12, 2021	SELL	$11.26 - $15.78 $352,088 - $493,424	-31,269 Reduced 7.72%	373,955 $4.6 Million
Q4 2020 Feb 11, 2021	SELL	$10.17 - $14.56 $114,707 - $164,222	-11,279 Reduced 2.71%	405,224 $5.71 Million
Q3 2020 Nov 16, 2020	BUY	$9.68 - $17.01 $2.68 Million - $4.7 Million	276,425 Added 197.34%	416,503 $5 Million
Q2 2020 Aug 14, 2020	BUY	$9.95 - $17.05 $643,148 - $1.1 Million	64,638 Added 85.68%	140,078 $2.33 Million
Q1 2020 May 14, 2020	BUY	$6.12 - $13.64 $126,506 - $281,952	20,671 Added 37.74%	75,440 $859,000
Q4 2019 Feb 14, 2020	BUY	$2.65 - $12.72 $21,820 - $104,736	8,234 Added 17.69%	54,769 $675,000
Q3 2019 Nov 13, 2019	BUY	$2.33 - $3.76 $108,426 - $174,971	46,535 New	46,535 $133,000

199K

Ticker NLTX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,579,900
Description
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.